The practice is making a decision based on what is easiest for the surgery, not what is best for the patient
(In other words, forgive me if I didnt define something in a way more familiar to you.) Below is a brief overview of research on mast cell activation disorders, which is an umbrella term covering several distinct diseases, including: Lets go into the first two in a little more detail, and then focus on MCAS
Yes, they can be used together in some cases because they serve different purposes
If a BPC-157 plus TB-500 combination is not producing results after 4 to 6 weeks, the comprehensive stack with GHK-Cu may be worth exploring
Fine line reduction (weeks 6 to 12): shallow dynamic lines around the eyes and mouth soften as the surrounding matrix becomes better hydrated and structurally supported
But it may cause more discomfort during insertion